Philip Greenberg, Fred Hutchinson Cancer Research Center (IMAGE)
Caption
Dr. Philip Greenberg, head of immunology and a member of the Clinical Research Division at Seattle's Fred Hutchinson Cancer Research Center and a leader in cancer immunology, will describe how he and colleagues are genetically engineering T cells to seek out cancer cells, penetrate their defenses and kill them.
Credit
Fred Hutch News Service
Usage Restrictions
None
License
Licensed content